Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Ardelyx licenses NaPi-2b phosphate inhibitor program to Sanofi

Feb. 25, 2014

Dosing completed in phase II trial of GCS-100 for chronic kidney disease

Feb. 24, 2014

Regulus Therapeutics nominates RG-012 as candidate for Alport syndrome

Feb. 21, 2014

Japanese researchers claim new prostanoid EP1 receptor antagonists

Feb. 17, 2014

Astellas reports melatonin agonists for urinary incontinence

Jan. 29, 2014

Japan Tobacco and Torii gain approval for Riona Tablets in Japan

Jan. 17, 2014

Extended treatment phase of ZS-9 phase III trial in hyperkalemia meets endpoint

Jan. 15, 2014

Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access

Jan. 10, 2014

Development and characterization of an orally available antifibrotic drug to treat renal fibrosis

Jan. 2, 2014

Novel autotaxin inhibitors synthesized by Roche

Dec. 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...